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Abstract p62 is a novel immediate early response gene encoding
a ubiquitin chain binding protein. To investigate the mechanism
of p62 gene expression, we isolated and characterized the 20 kb
long human p62 gene. The p62 gene contains seven introns and
eight exons. The splice sites conformed to the GT/AG rule,
except introns 6 and 7 which used the unusual GC dinucleotides.
The p62 promoter is TATA-less, and 357 nucleotides of the
5P-flanking region contain basic machineries for transcription. A
reporter gene linked to 1800 nucleotides of the 5P-flanking region
was rapidly activated by various extracellular signals. The
presence of a CpG island as well as multiple binding sites for SP-
1, AP-1, NF-UB, and Ets-1 family in the promoter region
supports the regulated activation of the p62 gene.
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1. Introduction
p62 is a cytoplasmic protein originally identi¢ed as a phos-
photyrosine-independent ligand of the SH2 domain of p56lck
[1]. p62 is expressed in most tissues and also binds to ubiquitin
and atypical PKC j [2,3]. Ubiquitin chain conjugation is crit-
ical in regulation of cell proliferation by controlling catabo-
lism of key regulatory proteins at the proteasome or the endo-
some/lysosome [4,5]. Proteasomal recognition of substrates is
initiated by a proteasomal multiubiquitin chain binding pro-
tein(s) [6,7]. Interestingly, p62 also has high a⁄nity to multi-
ubiquitin chains (Ko et al., submitted). The molecules to
which it binds suggest that p62 is likely involved in a regu-
lation of ubiquitinated protein metabolism.
Recently, we also found that a variety of signals, including
those which stimulate proliferation and di¡erentiation, rapidly
induces the transcriptional activation of the p62 gene (Lee et
al., submitted). Interestingly, the mechanism by which p62 is
activated is similar to that of immediate early response genes.
Furthermore, a murine p62 homolog A170 gene is activated
by oxidative stress in murine intestinal macrophage [8]. Thus,
analysis of the genetic regulation of p62 expression would be
important for extracellular signal-mediated protein metabo-
lism. To this end, in the present study, we have analyzed
the 20 kb long human p62 gene locus, including its genomic
organization and promoter analysis. These results will provide
the way for further analysis of p62 gene regulation.
2. Materials and methods
2.1. Genomic library screening
106 plaques of a Lambda FixII genomic library of human placenta
(Stratagene, La Jolla, CA) were screened using 5P-end labeled full
length p62 cDNA as a probe. Hybridization was carried out at
42‡C in formamide bu¡er [9]. Two positive clones, p62-V1 and p62-
V2, were hybridized by the 5P and 3P halves of p62 cDNA respectively
and were further characterized. Restriction digested fragments of the
puri¢ed V DNAs were subcloned into pBluescript and analyzed. The
5P-£anking region, exons and their boundaries were directly sequenced
on both strands from the clones using Sequenase kit (USB, Cleveland,
OH). Introns were ampli¢ed from the genomic clones using a long-
range PCR kit (Promega, Madison, WI) and primers derived from
within the adjacent exons.
2.2. Primer extension
Poly(A) mRNA was isolated from HeLa cells with mRNA separa-
tor kit (Clontech, Palo Alto, CA). An antisense oligonucleotide pri-
mer 5P-ggtcccgccggcactctttt-3P derived from the region +326 to +305
bases to the translation initiation site of p62 cDNA [1] was synthe-
sized and 5P-end labeled with [Q-32P]ATP using T4 polynucleotide
kinase. 10 pmol of the end labeled primer was annealed to 5 Wg of
poly(A) mRNA at 52‡C. Extension was performed at 42‡C for 1 h
with 10 units of AMV reverse transcriptase (Promega) and analyzed
on a 5% polyacrylamide gel.
2.3. Reporter plasmid construction and expression
The 5P-£anking region was isolated by BamHI-BsiEI digestion from
the 6 kb BamHI fragment of p62V1. These enzymes liberate a 1818 bp
long fragment from the 5P cloning site (BamHI) to 10 bp downstream
of the transcription start site (BsiEI). Both ends of the fragment were
blunt ended using T4 polymerase then ligated to upstream of lucifer-
ase gene in PGL3 basic vector (Promega) (PGL3.p62:31808/+10).
A construct containing the same fragment with inverse orienta-
tion (PGL3.p62:+10/31808) was also isolated and used as a neg-
ative control. PGL3.p62:31408/+10, PGL3.p62:3873/+10, and
PGL3.p62:3357/+10 were similarly constructed by ligating restriction
fragments of StuI-BsiEI, BstEII-BsiEI, and KpnI-BsiEI digestion re-
spectively. 6U105 NIH3T3 ¢broblast cells were transfected using lipo-
fectin (Gibco-BRL, Gaithersburg, MD) with 3 Wg each of the various
reporter constructs. At 48 h post transfection, cells were washed with
PBS, and luciferase activity contained in the cells was measured
by following the procedure described by Williams et al. [10]. To
measure serum-induced activation, NIH3T3 cells transfected with
PGL3.p62:31808/+10 were serum starved for 48 h, incubated further
in the presence of 15% fetal bovine serum for the indicated time, and
luciferase activity contained in the cells was measured. Transfection
e⁄ciency was normalized by L-galactosidase activity which was ex-
pressed by cotransfection with a plasmid containing CMV promoter-
linked L-galactosidase gene (pCMV.L-gal). L-Galactosidase activity
was measured using Luminescent L-gal detection kit (Clontech, Palo
Alto, CA).
3. Results and discussion
3.1. Genomic organization of the p62 gene
p62 cDNA was used to screen 106 plaques of a Lambda
FixII genomic library of human placenta (Stratagene). Two
overlapping positive clones (p62-V1 and p62-V2) cover full
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length p62 cDNA (Fig. 1). The p62 gene contains eight exons
ranging in size from 81 bp to 872 bp. The exon sequence is
identical to the previously reported p62 cDNA sequence [1].
Exon-1 contains the ATG translation initiation codon and the
5P-untranslated region (UTR), while exon 8 has stop codon
and 3P-UTR (Fig. 1 and Table 1). The sizes of introns range
from 200 bp to 8 kb.
All intron and exon splice sites follow the AG/GT rule [11]
except introns 6 and 7 which have GC in the 5P splice donor
site (Table 1). Although rare, this functional splice sequence
has been previously noted in several genes [12] and implicated
for alternative splicing [13]. However, the alternatively spliced
p62 message was not detected in any tissues [1].
3.2. Transcription start site
The transcription start site of p62 gene was estimated using
primer extension analysis with an oligonucleotide complemen-
tary to the region +326/+305 bp of the translation initiation
site of p62 cDNA [1]. As shown in Fig. 2, primer extension
yielded a major band running between 311 nt and 427 nt size
markers (lane 2), while no extension products were observed
when mRNA was omitted (lane 1) or substituted with yeast
transfer RNA (lane 3). Based on relative mobility measured in
three independent experiments, the size of the extended primer
was estimated to be about 380 nt. This result indicates that
the transcription start site of the p62 gene is likely located
between 350 nt and 360 nt from the ATG translation initia-
tion site. In the previous report, HeLa p62 cDNA started with
a GCGCGGCGGCTG sequence which is 52 nt upstream of
the ATG translation initiation site [1]. Furthermore, 5P-RACE
using HeLa poly(A) mRNA also resulted in the same 5P-end
sequence (data not shown). Thus, it is tentatively concluded
that the transcription start site of the p62 gene is likely located
at 352 nucleotides from the translation initiation site (Fig. 3).
3.3. Characterization of the 5P-£anking region of p62 gene
A 6 kb BamHI fragment of p62-V1 covers the 1.8 kb long
5P-£anking region in addition to the ¢rst ¢ve exons of p62
gene (Fig. 1). Interestingly, the 5P-£anking region of the p62
gene lacks both TATA and CAAT boxes (Fig. 3). Instead,
immediately upstream (within 100 bp 5P) of the transcription
start site there is a very G/C rich region which contains three
consensus sequences for SP1 transcription factor binding. Sp1
is a ubiquitous zinc ¢nger containing transcription factor,
and, in many cases, responsible for transcription of genes
containing TATA-less promoters [14].
In order to analyze the functional promoter activity of the
cloned 5P-£anking region of the p62 gene, various lengths of
the 5P-£anking region were subcloned into PGL3 basic vector
upstream of the luciferase gene. NIH3T3 cells were trans-
fected with these constructs and activation of the luciferase
gene was measured. Signi¢cant increase of luciferase activity
was observed in cells transfected with PGL3.p62[3357/+10]
(Fig. 4A). Transfection of PGL3.p62[3873/+10] induced luci-
ferase activity similar to that of PGL3.p62[3357/+10]. How-
ever, addition of 535 bp (PGL3.p62[31408/+10]) or 935 bp
(PGL3.p62[31808/+10]) further upstream induced much in-
creased luciferase activity, fourfold higher than that by
PGL3.p62[3357/+10] or PGL3.p62[3873/+10]. Under the
same condition, luciferase activity was minimal in cells trans-
fected with PGL3 basic vector or with PGL3.p62[+10/31808]
in which the 5P-£anking region of p62 is inversely linked to
the luciferase gene. These results suggest that the basic machi-
nery for p62 gene transcription lies within 357 nucleotides 5P
of the transcription start site, and that a strong enhancer
element is contained in the region 3873 to 31408.
3.4. The p62 promoter contains elements for the induced
expression
Highly elevated transcript and protein levels of p62 have
been observed during G0 exit in peripheral blood mononu-
cleocytes and serum-starved NIH3T3 ¢broblasts, during early
G1 progression in a pre-B cell line Ba/F3, during monocytic
di¡erentiation of a promyelocyte U937 (Lee et al., submitted),
and upon oxidative stress in murine intestinal macrophages
[8].
Thus, signal-induced activation of p62 promoter was exam-
ined. NIH3T3 cells transfected with PGL3.p62[31808/+10]
were incubated in the presence or absence of 10% fetal bovine
serum (FBS) for 48 h. About fourfold higher luciferase activ-
ity driven by the p62 promoter was observed in the cells
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Fig. 1. Schematic representation of p62 genomic organization. Struc-
ture of the p62 gene was deduced from analysis of two overlapping
clones p62-V1 and p62-V2. The con¢rmed restriction enzyme sites
are shown for BamHI (B), EcoRI (E) and HindIII (H). Eight exons
are shown at the bottom with open rectangles.
Table 1
Exon/intron organization of the p62 gene
Exon number Exon length (nt) 5P-Splice donor (nt) Intron length 3P-Splice donor
1 286 ACGGGG/gtgagc 1500 atctag/ACTTGG
2 84 TTAAAG/gtgagc 900 ctgtag/AGAAAA
3 230 TCTGAG/gtgagc 200 ccccag/GGCTTC
4 142 AATCAG/gtgagg 800 tcaaag/CTTCTG
5 81 CTCTGG/gtgatg 8000 ctctag/GCATTG
6 216 CCTGAG/gcaagc 500 ttccag/GAACAG
7 195 CGCCAG/gcaagt 2200 cggcag/AGGCTG
8 872
Exon sequences are in uppercase letters and intron sequences in lowercase.
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cultured in the presence of 10% FBS compared to that in the
serum-starved cells (Fig. 4B). Furthermore, when the serum-
starved cells were stimulated with 15% FBS, luciferase activity
was rapidly increased to submaximal level 1 h after serum
treatment (Fig. 4C). The induced activity was decreased to
some extent for the next 5 h, increased again to 2.5-fold by
9 h post stimulation, and then maintained the activity for the
next 15 h. On the other hand, without serum stimulation, the
luciferase activity was maintained at relatively low, albeit sig-
ni¢cant, levels.
In U937 cells, under normal growing condition, luciferase
activity expressed by PGL3.p62[31808/+10] maintained its
relatively low level (Fig. 4D). Upon PMA treatment, an in-
crease of luciferase activity was observed in 1 h and a sharp
surge of the activity followed at 3^4 h post stimulation. After
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Fig. 2. Transcription initiation site analysis by primer extension. A
primer corresponding to the +326 to +305 bp region of p62 cDNA
was annealed to 5 Wg of HeLa poly(A) mRNA, and extended by
AMV reverse transcriptase (lane 3). As negative controls, the same
primer extension was performed either in the presence of 5 Wg yeast
tRNA instead of HeLa poly(A) mRNA (lane 4) or in the absence
of any RNA (lane 2). Molecular size markers in nucleotides (nt) are
shown on the left (lane 1).
6
Fig. 3. Nucleotide sequence of the 5P-£anking region and the ¢rst exon of the p62 gene. The putative transcription start site identi¢ed by prim-
er extension is indicated by an arrowhead, and the ATG translation initiation site by a box. The numbers on the left are relative to the guano-
sine of the putative transcription start site. Exon 1 is shown in boldface letters, and deduced amino acid sequences in boldface capital letters.
Consensus binding sequences for the known transcription factors are underlined. The nucleotide sequence was deposited in the GenBank under
accession number AF060494.
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a temporary 40% reduction, the induced luciferase activity
upregulated again and was maintained thereafter. These re-
sults con¢rm that the cloned 5P-£anking region contains cis-
element(s) responsible for activation of the p62 gene during
cell proliferation and di¡erentiation.
Nevertheless, the promoter of the p62 gene likely has multi-
ple regulatory features for responding to divergent signals in
various tissues. Indeed, the p62 promoter sequence shows the
presence of a number of potential binding sites for known
transcription factors (Fig. 3). These include three TPA-re-
sponsive element (TRE) sites which are known to be high
a⁄nity binding sites for heterodimers between Fos- and
Jun-related bZip proteins or Jun homodimers [15,16]. Another
characteristic of the p62 promoter region is the presence of
multiple binding sites for Ets-1 family transcription factors,
including two Ets-1 sites, six PEA3 sites, and two Pu.1 sites
(Fig. 3, and [17]). PEA3 is induced by TPA, serum, EGF,
v-src, v-raf, or Ha-ras, thus representing a primary target of
mitogenic signal transduction pathways [17,18]. Pu.1 is anoth-
er Ets-1 family member known to be involved in monocytic
di¡erentiation of bone marrow progenitor cells [19]. An NF-
UB and a c-myc binding site are also present at 31724 and
31329 respectively. Thus, these cis-elements would be respon-
sible, at least partly, for activation of the p62 gene upon
signals for proliferation, di¡erentiation, and oxidative stress.
Interestingly, the proximal promoter region and extending
into the ¢rst exon (3950 to +267) has a high G/C content up
to 73%, and is enriched with CpG dinucleotides; the ratio of
CpG to GpC in this region is 0.93. Such high G/C content
and high frequency of CpG dinucleotides ful¢l the de¢nition
of CpG islands [20]. Genes containing a CpG island in their
promoter region including housekeeping genes, transcription
factors, and oncogenic proteins are essential for cell vitality
and their activities are highly regulated. One determinant for
the relative activity of a promoter containing CpG islands is
the state of methylation of cytosine residues in 5P-CpG dinu-
cleotides [20,21]. Further analysis is required to evaluate the
signi¢cance of CpG island and various cis-elements present in
the promoter region of the p62 gene.
p62 interacts with multiubiquitin chains. However, unlike
proteasomal multiubiquitin chain binding protein Mcb1/S5a,
p62 is localized only in the cytoplasm and is not physically
associated with the proteasome (Ko et al., submitted). Thus, it
is likely that the immediate early response of the p62 gene is
essential in cell growth, di¡erentiation, and oxidative stress
through a novel mechanism regulating protein metabolism.
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Fig. 4. Activation of the p62 promoter. A: Promoter activity of the 5P-£anking region of the p62 gene. Constructed luciferase reporter plasmids
are illustrated on the left (see Section 2). The reporter plasmids were cotransfected with pCMV.L-gal into NIH3T3 cells. The e¡ects of the
5P-£anking sequences on luciferase expression were normalized to L-galactosidase activity, and are expressed as relative light units (RLU).
B: p62 promoter activity in NIH3T3 cells in the presence and absence of 10% serum. C, D: Time-dependent changes in the p62 promoter ac-
tivity of serum-starved NIH3T3 (C) and U937 (D) cells after stimulation with 15% serum and 20 ng/ml PMA respectively. Luciferase activities
driven by PGL3.p62[31808/+10] in stimulated (closed circles) and unstimulated (open circles) cells and those by PGL3 (open square and cross)
are shown. The results are representative of more than three independent experiments.
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Information provided in this article will be useful in further
studies to provide more insight into the mechanisms regulat-
ing the p62 gene.
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